James M. Fleckenstein

4.7k total citations
81 papers, 3.2k citations indexed

About

James M. Fleckenstein is a scholar working on Endocrinology, Infectious Diseases and Food Science. According to data from OpenAlex, James M. Fleckenstein has authored 81 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Endocrinology, 37 papers in Infectious Diseases and 16 papers in Food Science. Recurrent topics in James M. Fleckenstein's work include Escherichia coli research studies (53 papers), Viral gastroenteritis research and epidemiology (34 papers) and Antibiotic Resistance in Bacteria (14 papers). James M. Fleckenstein is often cited by papers focused on Escherichia coli research studies (53 papers), Viral gastroenteritis research and epidemiology (34 papers) and Antibiotic Resistance in Bacteria (14 papers). James M. Fleckenstein collaborates with scholars based in United States, Bangladesh and Sweden. James M. Fleckenstein's co-authors include Koushik Roy, Alaullah Sheikh, David A. Rasko, Qingwei Luo, David J. Hamilton, Kenneth P. Allen, Firdausi Qadri, George P. Munson, Philip R. Hardwidge and Tim J. Vickers and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James M. Fleckenstein

80 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. Fleckenstein United States 33 1.8k 1.3k 650 617 538 81 3.2k
Richard Haigh United Kingdom 28 729 0.4× 632 0.5× 1.1k 1.7× 459 0.7× 256 0.5× 55 2.7k
Peter Fleming Canada 22 1.3k 0.7× 1.2k 0.9× 532 0.8× 705 1.1× 400 0.7× 42 3.3k
Primrose Freestone United Kingdom 31 619 0.3× 610 0.5× 1.5k 2.2× 487 0.8× 192 0.4× 56 3.1k
Gail Hecht United States 47 1.9k 1.0× 1.8k 1.4× 2.7k 4.1× 777 1.3× 204 0.4× 119 6.4k
Nathalie Rolhion France 25 504 0.3× 485 0.4× 1.4k 2.2× 433 0.7× 150 0.3× 40 2.5k
Sean D. Reid United States 26 463 0.3× 860 0.7× 542 0.8× 209 0.3× 94 0.2× 48 2.5k
Natasha A. Barry United States 12 316 0.2× 686 0.5× 2.3k 3.5× 436 0.7× 115 0.2× 13 3.3k
N. Cary Engleberg United States 31 1.3k 0.7× 864 0.7× 1.1k 1.6× 99 0.2× 115 0.2× 61 3.5k
Tadahiro Karasawa Japan 33 397 0.2× 1.3k 1.0× 551 0.8× 245 0.4× 84 0.2× 70 2.7k
Toby K. Eisenstein United States 41 427 0.2× 638 0.5× 1.4k 2.1× 727 1.2× 111 0.2× 122 4.8k

Countries citing papers authored by James M. Fleckenstein

Since Specialization
Citations

This map shows the geographic impact of James M. Fleckenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Fleckenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Fleckenstein more than expected).

Fields of papers citing papers by James M. Fleckenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Fleckenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Fleckenstein. The network helps show where James M. Fleckenstein may publish in the future.

Co-authorship network of co-authors of James M. Fleckenstein

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Fleckenstein. A scholar is included among the top collaborators of James M. Fleckenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Fleckenstein. James M. Fleckenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svensson, Frida, Liisa Arike, Jenny K. Gustafsson, et al.. (2025). EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural features. Nature Communications. 17(1). 158–158.
2.
Sheikh, Alaullah, Tim J. Vickers, Bernhard B. Singer, et al.. (2024). Host-derived CEACAM-laden vesicles engage enterotoxigenic Escherichia coli for elimination and toxin neutralization. Proceedings of the National Academy of Sciences. 121(38). e2410679121–e2410679121. 1 indexed citations
3.
Fleckenstein, James M., et al.. (2023). Structural and biophysical characterization of the secreted, β-helical adhesin EtpA of Enterotoxigenic Escherichia coli. PLoS ONE. 18(6). e0287100–e0287100. 2 indexed citations
4.
Sheikh, Alaullah, Tim J. Vickers, John Martin, et al.. (2022). Enterotoxigenic Escherichia coli heat-labile toxin drives enteropathic changes in small intestinal epithelia. Nature Communications. 13(1). 6886–6886. 24 indexed citations
5.
Sheikh, Alaullah, Tamding Wangdi, Tim J. Vickers, et al.. (2022). Enterotoxigenic Escherichia coli degrades the host MUC2 mucin barrier to facilitate critical pathogen-enterocyte interactions in human small intestine. Digital Commons@Becker (Washington University School of Medicine). 24 indexed citations
6.
Kuhlmann, F, Sadia Afrin, Rie Nakajima, et al.. (2021). Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli. Infection and Immunity. 89(5). 17 indexed citations
7.
Foulke‐Abel, Jennifer, Huimin Yu, Laxmi Sunuwar, et al.. (2020). Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during enterotoxigenic Escherichia coli infection. Gut Microbes. 12(1). 1752125–1752125. 17 indexed citations
8.
Cox, Eric, Meryem Aloulou, James M. Fleckenstein, et al.. (2020). The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting. Applied and Environmental Microbiology. 86(24). 5 indexed citations
9.
Sheikh, Alaullah, Tim J. Vickers, David M. Alvarado, et al.. (2020). CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli. Proceedings of the National Academy of Sciences. 117(46). 29055–29062. 29 indexed citations
10.
Kuhlmann, F, John Martin, Tracy H. Hazen, et al.. (2019). Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli. PLoS neglected tropical diseases. 13(11). e0007825–e0007825. 27 indexed citations
11.
Rasko, David A., Felipe Del Canto, Qingwei Luo, et al.. (2019). Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile. PLoS neglected tropical diseases. 13(11). e0007828–e0007828. 17 indexed citations
12.
Sunuwar, Laxmi, Jianyi Yin, Magdalena Kasendra, et al.. (2019). Mechanical Stimuli Affect Escherichia coli Heat-Stable Enterotoxin-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Model. Infection and Immunity. 88(3). 35 indexed citations
13.
Chakraborty, Subhra, Arlo Randall, Tim J. Vickers, et al.. (2019). Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection. npj Vaccines. 4(1). 37–37. 26 indexed citations
14.
Zhu, Yue‐Hui, et al.. (2018). Molecular Determinants of Enterotoxigenic Escherichia coli Heat-Stable Toxin Secretion and Delivery. Infection and Immunity. 86(11). 23 indexed citations
15.
Sheikh, Alaullah, Rasheduzzaman Rashu, Yasmin Ara Begum, et al.. (2017). Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions. PLoS neglected tropical diseases. 11(5). e0005586–e0005586. 40 indexed citations
16.
Kumar, Pardeep, F Kuhlmann, Kirandeep Bhullar, et al.. (2016). Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery. Infection and Immunity. 84(12). 3608–3617. 27 indexed citations
17.
Luo, Qingwei, Tim J. Vickers, & James M. Fleckenstein. (2016). Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin. Clinical and Vaccine Immunology. 23(7). 628–637. 25 indexed citations
18.
Luo, Qingwei, Firdausi Qadri, Rita G. Kansal, et al.. (2015). Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli. PLoS neglected tropical diseases. 9(1). e0003446–e0003446. 53 indexed citations
19.
Fleckenstein, James M. & Dennis J. Kopecko. (2001). Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens. Journal of Clinical Investigation. 107(1). 27–30. 39 indexed citations
20.
Wortmann, Glenn & James M. Fleckenstein. (1998). Incidental Discovery of Emphysematous Cystitis. Southern Medical Journal. 91(8). 785–786. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026